Current Medicinal Chemistry

Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge


Stem Cells: An Overview of the Current Status of Therapies for Central and Peripheral Nervous System Diseases

Author(s): A. Orlacchio, G. Bernardi and S. Martino

Affiliation: Laboratorio di Neurogenetica, Centro Europeo di Ricerca sul Cervello (CERC), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Santa Lucia, 64 Via del Fosso di Fiorano, 00143 Rome, Italy.


In regenerative medicine, stem cells are currently considered ideal candidates for the treatment of diseases and injuries of the nervous system, for which, at present, there are no effective treatments. Promising results have been shown by clinical trials for neurodegenerative diseases such as Parkinsons diseases, but also for demyelinising disorders and traumatic lesions of the brain and spinal cord. The proof-of-principle is that the replacement of damaged cells and the restoration of function can be accomplished by the transplantation of embryonic or adult stem cells. Advancements in stem cell biology were recently propelled by the ability to generate induced pluripotent stem (iPS) cells from fibroblasts of several neurodegenerative diseases (e.g. Parkinsons and Huntingtons diseases, Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy). In this review, we discuss the molecular basis of stem cell therapy and the advancement of research on regenerative medicine for diseases and injuries of the nervous system.

Keywords: Embryonic Stem cells, Adult Stem Cells, induced Pluripotent stem cells, central and peripheral nervous system diseases, stem cell therapy

Order Reprints Order Eprints Rights & PermissionsPrintExport

Article Details

Page: [595 - 608]
Pages: 14
DOI: 10.2174/092986710790416272